#foundayo — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #foundayo, aggregated by home.social.
-
https://www.europesays.com/dk/76750/ Novo Nordisk Q1 2026 Earnings: Revenue, Profit Beat; Full-Year Forecast Narrowed | Reuters – News and Statistics #EliLilly #Foundayo #Mounjaro #NovoNordisk #NovoLog #Victoza #Wegovy #WegovyPill #ZeitaLevemir
-
https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill
-
https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
Eli Lilly's Oral Weight-Loss Drug Sees Initial Uptake Amidst Regulatory Scrutiny
Eli Lilly's new oral weight-loss drug Foundayo had 1,400 prescriptions in its first week. The FDA is checking its safety. Find out who is affected.
#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron
https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/
-
Eli Lilly's Foundayo drug received nearly 1,400 prescriptions in its first week, showing strong initial demand. This is a new oral option for weight loss.
#Foundayo, #EliLilly, #WeightLossDrug, #FDASafety, #Orforglipron
https://newsletter.tf/eli-lilly-foundayo-drug-fda-safety-checks/ -
Update: New Options for Weight Loss
The landscape of metabolic medicine is shifting beneath our feet. For the last few years, the conversation has been dominated by weekly injections like #Zepbound (#tirzepatide), #Wegovy (#semaglutide), #Foundayo (#orforglipron) and #retatrutide.